All In MedTech

Device Trial Radar · NCT06432881

Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)

Last checked: Nov 20, 2026Latest source record: Jul 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

461

Actual

Start

Jan 8, 2024

Primary completion

Jul 7, 2026

Study completion Jul 7, 2026

Sponsor

Lead sponsor
Masimo CorporationPublic (MASI)
Sponsor type
Industry
First posted
May 29, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 89 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the performance of Masimo RD SET® SpO2 sensors in subjects with light and dark skin pigmentation in the intensive care therapeutic area.

Conditions

  • Hypoxemia

Interventions

  • RD SET SensorDevice

    All subjects are enrolled into this arm and will have Sp02 measurements obtained.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Investigation of skin pigmentation effect on performance of Masimo pulse oximetryTime frame: Approximately 30 minutes

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Medical University of South Carolina

    Charleston, South Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.